Home Applications 211746 Application 211746
Type NDA
Sponsor GLENMARK SPECIALTY SA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 RYALTRIS OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE MONOHYDRATE SPRAY, METERED;NASAL 665MCG/25MCG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N211746-001 RYALTRIS MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13
Orange Book patents# Current patent rows page 1 of 1 · 17 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N211746-001 10016443 2034-09-04 U-3297 2022-02-11 N211746-001 10376526 2034-09-04 Drug product 2022-02-11 N211746-001 10517880 2034-09-04 U-3297 Drug product 2022-02-11 N211746-001 10548907 2034-09-04 U-3297 2022-02-11 N211746-001 10561672 2034-09-04 Drug product 2022-02-11 N211746-001 10646500 2034-09-04 U-3297 2022-02-11 N211746-001 10758550 2034-09-04 U-3296 2022-02-11 N211746-001 10765686 2034-09-04 U-3295 2022-02-11 N211746-001 11400101 2034-09-04 U-3297 2022-08-25 N211746-001 12064442 2034-09-04 U-3297 2024-09-12 N211746-001 9078923 2034-09-04 U-3297 Drug product 2022-02-11 N211746-001 9370483 2034-09-04 Drug product 2022-02-11 N211746-001 9750754 2034-09-04 U-3297 Drug product 2022-02-11 N211746-001 9937189 2034-09-04 Drug product 2022-02-11 N211746-001 11679210 2038-09-03 Drug product 2023-07-20 N211746-001 12303635 2039-04-08 Drug substance, Drug product 2025-06-06 N211746-001 12653833 2044-11-21 U-4564 Drug product 2026-07-09
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N211746-001 NPP 2029-07-07
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 bb7c543d1eb4…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N211746-001 RYALTRIS 0.025MG/SPRAY;0.665MG/SPRAY SPRAY, METERED / NASAL RLD, RS 2022-01-13 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 12 · 450 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N211746-001 10016443 2034-09-04 U-3297 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10376526 2034-09-04 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10517880 2034-09-04 U-3297 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10548907 2034-09-04 U-3297 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10561672 2034-09-04 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10646500 2034-09-04 U-3297 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10758550 2034-09-04 U-3296 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 10765686 2034-09-04 U-3295 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 11400101 2034-09-04 U-3297 2022-08-25 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 12064442 2034-09-04 U-3297 2024-09-12 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 9078923 2034-09-04 U-3297 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 9370483 2034-09-04 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 9750754 2034-09-04 U-3297 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 9937189 2034-09-04 Drug product 2022-02-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 11679210 2038-09-03 Drug product 2023-07-20 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 12303635 2039-04-08 Drug substance, Drug product 2025-06-06 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N211746-001 12653833 2044-11-21 U-4564 Drug product 2026-07-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N211746-001 10016443 2034-09-04 U-3297 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10376526 2034-09-04 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10517880 2034-09-04 U-3297 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10548907 2034-09-04 U-3297 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10561672 2034-09-04 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10646500 2034-09-04 U-3297 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10758550 2034-09-04 U-3296 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 10765686 2034-09-04 U-3295 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 11400101 2034-09-04 U-3297 2022-08-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 12064442 2034-09-04 U-3297 2024-09-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 9078923 2034-09-04 U-3297 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 9370483 2034-09-04 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 9750754 2034-09-04 U-3297 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 9937189 2034-09-04 Drug product 2022-02-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 11679210 2038-09-03 Drug product 2023-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N211746-001 12303635 2039-04-08 Drug substance, Drug product 2025-06-06 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10016443 2034-09-04 U-3297 2022-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10376526 2034-09-04 Drug product 2022-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10517880 2034-09-04 U-3297 Drug product 2022-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10548907 2034-09-04 U-3297 2022-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10561672 2034-09-04 Drug product 2022-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10646500 2034-09-04 U-3297 2022-02-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N211746-001 10758550 2034-09-04 U-3296 2022-02-11 31067a03dcf5…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 59467-700 Ryaltris olopatadine hydrochloride and mometasone furoate HIKMA SPECIALTY USA INC. NDA Current 59467-700 Ryaltris olopatadine hydrochloride and mometasone furoate HIKMA SPECIALTY USA INC. NDA Current 59467-700 Ryaltris olopatadine hydrochloride and mometasone furoate HIKMA SPECIALTY USA INC. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 75328 SUPPL 2023-08-31 75319 SUPPL 2023-08-30 74622 SUPPL 2023-06-26 74621 SUPPL 2023-06-26 73138 ORIG 2023-01-10 72253 SUPPL 2022-10-05 72211 SUPPL 2022-10-03 69895 ORIG 2022-01-18 69893 ORIG 2022-01-18